日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Characterizing Self-Reported Daily Diary Epistaxis Measures in Hereditary Hemorrhagic Telangiectasia

对遗传性出血性毛细血管扩张症患者自我报告的每日鼻出血日记测量结果进行特征分析

Tarulli, C M; Ma, X; Bayoumi, A M; Patel, A; Vozoris, N T; Lee, J M; Faughnan, M E

Randomized, double-blind, placebo-controlled, crossover trial of oral doxycycline for epistaxis in hereditary hemorrhagic telangiectasia.

随机、双盲、安慰剂对照、交叉试验,研究口服多西环素治疗遗传性出血性毛细血管扩张症鼻出血的疗效

Thompson K P, Sykes J, Chandakkar P, Marambaud P, Vozoris N T, Marchuk D A, Faughnan M E

Utility of modified Rankin Scale for brain vascular malformations in hereditary hemorrhagic telangiectasia

改良Rankin量表在遗传性出血性毛细血管扩张症脑血管畸形中的应用

Thompson, K P; Nelson, J; Kim, H; Weinsheimer, S M; Marchuk, D A; Lawton, M T; Krings, T; Faughnan, M E

Life expextancy of parents with Hereditary Haemorrhagic Telangiectasia

患有遗传性出血性毛细血管扩张症的父母的预期寿命

de Gussem, E M; Edwards, C P; Hosman, A E; Westermann, C J J; Snijder, R J; Faughnan, M E; Mager, J J

Neurovascular manifestations in hereditary hemorrhagic telangiectasia: imaging features and genotype-phenotype correlations

遗传性出血性毛细血管扩张症的神经血管表现:影像学特征和基因型-表型相关性

Krings, T; Kim, H; Power, S; Nelson, J; Faughnan, M E; Young, W L; terBrugge, K G

Visceral manifestations in hereditary haemorrhagic telangiectasia type 2

遗传性出血性毛细血管扩张症2型的内脏表现

Abdalla, S A; Geisthoff, U W; Bonneau, D; Plauchu, H; McDonald, J; Kennedy, S; Faughnan, M E; Letarte, M

Potential role of modifier genes influencing transforming growth factor-beta1 levels in the development of vascular defects in endoglin heterozygous mice with hereditary hemorrhagic telangiectasia

影响转化生长因子-β1水平的修饰基因在遗传性出血性毛细血管扩张症内皮糖蛋白杂合子小鼠血管缺陷发展中的潜在作用

Bourdeau, A; Faughnan, M E; McDonald, M L; Paterson, A D; Wanless, I R; Letarte, M